Skip to main content
Caplight Logo









Joyvio Capital

Joyvio Capital

Overview

Joyvio Capital is the corporate venture capital arm of Joyvio Group, focusing on investments in biotechnology and food technology, with a core emphasis on alternative proteins and functional nutrients.

Year Founded

2012

Portfolio Companies

2

Investments

Joyvio Capital investments
CompanyDateStageLead
CellXMay 2022Series ACo-investor
Jimi BiotechNov 2022AngelCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Joyvio Capital based?

Joyvio Capital is headquartered in Beijing, China.

When was Joyvio Capital founded?

Joyvio Capital was founded in 2012.

How many portfolio companies does Joyvio Capital have?

Joyvio Capital has 2 portfolio companies in Caplight's dataset.

What are some companies in Joyvio Capital's portfolio?

Portfolio companies visible on Caplight include CellX, Jimi Biotech.

What was Joyvio Capital's most recent investment shown here?

Joyvio Capital's most recent investment in this portfolio sample was in Jimi Biotech in 2022.

What sectors does Joyvio Capital focus on?

Joyvio Capital focuses on Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences, Energy & Sustainability.

What company stages does Joyvio Capital focus on?

Joyvio Capital typically invests at the Early stage.

Firmographic Details

HeadquartersBeijing
Year Founded2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?